Anxiety and depression in chronic obstructive pulmonary disease:: a systematic review and meta-analysis.
Anxiety and depression in chronic obstructive pulmonary disease:: a systematic review and meta-analysis.
Background: Growing evidence from research indicates that Chronic Obstructive Pulmonary Disease(COPD) can increase the likelihood of patients suffering from anxiety and depression. However, there is little consensus about the prevalence and associated risk factors. The primary aim of this study was to systematically review the prevalence of anxiety and depression in patients with COPD. The secondary aim was to identify risk factors contributing to the comorbidity.
Methods: The study was conducted following PRISMA guidelines and was registered on PROSPERO. MEDLINE, Embase, PsychInfo and Web of Science were used to select relevant studies before 1st January 2023. A total of 4,420 studies were gathered after the initial search. 39 papers were included after meeting inclusion and exclusion criteria. Quality assessment was conducted using Hawker’s tool. The pooled prevalence was calculated using the random effects model via Comprehensive Meta-Analysis.
Results: The total sample size was 84,411 including 17,489 for anxiety and 66,922 for depression. The pooled prevalence for anxiety and depression were 29.8%(95% CI: 24.7%-35.5%) and 28.5%(95% CI: 21.3%-36.9%), respectively. Reported risk factors included gender, BMI, smoking, and severity of COPD. I2 test results derived from meta-analyses revealed substantial heterogeneity across studies due to the variability in study design.
Conclusions: This is the first meta-analysis that provides precise comorbidity and risk estimates of anxiety and depression in COPD. The study indicates higher prevalence of anxiety and depression in COPD suggesting the need for early assessment. The study also highlights females, higher BMI, smoking, and COPD with more exacerbation are contributing risk factors. Further research is warranted to examine underlying inflammatory mechanisms and identify modifiable risk factors which may offer new intervention approaches to benefit COPD patients with anxiety and depression.
Hou, Ruihua
470bdcbc-93a9-4dad-aac5-26d455c34376
Miah, Alina
c0fb1ece-5ed1-4079-ae65-f69f49b09059
15 June 2023
Hou, Ruihua
470bdcbc-93a9-4dad-aac5-26d455c34376
Miah, Alina
c0fb1ece-5ed1-4079-ae65-f69f49b09059
Hou, Ruihua and Miah, Alina
(2023)
Anxiety and depression in chronic obstructive pulmonary disease:: a systematic review and meta-analysis.
PsychoNeuroImmunology Research Society annual meeting, Boulder, US, Boulder US, Boulder, United States.
12 - 15 Jun 2023.
1 pp
.
Record type:
Conference or Workshop Item
(Poster)
Abstract
Background: Growing evidence from research indicates that Chronic Obstructive Pulmonary Disease(COPD) can increase the likelihood of patients suffering from anxiety and depression. However, there is little consensus about the prevalence and associated risk factors. The primary aim of this study was to systematically review the prevalence of anxiety and depression in patients with COPD. The secondary aim was to identify risk factors contributing to the comorbidity.
Methods: The study was conducted following PRISMA guidelines and was registered on PROSPERO. MEDLINE, Embase, PsychInfo and Web of Science were used to select relevant studies before 1st January 2023. A total of 4,420 studies were gathered after the initial search. 39 papers were included after meeting inclusion and exclusion criteria. Quality assessment was conducted using Hawker’s tool. The pooled prevalence was calculated using the random effects model via Comprehensive Meta-Analysis.
Results: The total sample size was 84,411 including 17,489 for anxiety and 66,922 for depression. The pooled prevalence for anxiety and depression were 29.8%(95% CI: 24.7%-35.5%) and 28.5%(95% CI: 21.3%-36.9%), respectively. Reported risk factors included gender, BMI, smoking, and severity of COPD. I2 test results derived from meta-analyses revealed substantial heterogeneity across studies due to the variability in study design.
Conclusions: This is the first meta-analysis that provides precise comorbidity and risk estimates of anxiety and depression in COPD. The study indicates higher prevalence of anxiety and depression in COPD suggesting the need for early assessment. The study also highlights females, higher BMI, smoking, and COPD with more exacerbation are contributing risk factors. Further research is warranted to examine underlying inflammatory mechanisms and identify modifiable risk factors which may offer new intervention approaches to benefit COPD patients with anxiety and depression.
Text
Poster final
- Version of Record
More information
Published date: 15 June 2023
Venue - Dates:
PsychoNeuroImmunology Research Society annual meeting, Boulder, US, Boulder US, Boulder, United States, 2023-06-12 - 2023-06-15
Identifiers
Local EPrints ID: 481161
URI: http://eprints.soton.ac.uk/id/eprint/481161
PURE UUID: 2d619dca-2d58-4721-8224-a8769f149d8e
Catalogue record
Date deposited: 16 Aug 2023 16:53
Last modified: 18 Mar 2024 03:07
Export record
Contributors
Author:
Alina Miah
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics